Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma
Conditions: Asthma Interventions: Drug: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate; Drug: Inhaled corticosteroids/long-acting beta-2 agonists Sponsors: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old
Conditions: Asthma Interventions: Drug: TEV-56248; Drug: Fp MDPI Sponsors: Teva Branded Pharmaceutical Products R&D, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
Conditions: Chronic Obstructive Pulmonary Disease Interventions: Drug: Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg; Drug: Comparator - Trimbow ® Sponsors: Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
BIOEQUIVALENCE STUDY OF AZELASTINE HYDROCHLORIDE/ FLUTICASONE PROPIONATE 137 Microgram/50 Microgram NASAL SPRAY AND'DYMISTA' (AZELASTINE HYDROCHLORIDE/ FLUTICASONE PROPIONATE) NASAL SPRAY 137 Microgram/50 Microgram
Conditions: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis Interventions: Drug: Azelastine Hydrochloride/ Fluticasone propionate nasal spray; Drug: ' DYMISTA ' NASAL SPRAY Sponsors: Humanis Sagl ık Anonim Sirketi Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
Role of Lung Function for Exercise Capacity in Well-trained Individuals
Conditions: Exercise Performance Interventions: Drug: Vilanterol and Fluticasone Furoate; Drug: Indacaterol and Mometasone Furoate; Drug: Placebo Sponsors: Morten Hostrup, PhD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
U-LABA/ICS Effects on Exercise Performance, Vilanterol
Conditions: Exercise Performance Interventions: Drug: Vilanterol and Fluticasone Furoate (low dose); Drug: Vilanterol and Fluticasone Furoate (high dose); Drug: Placebo Sponsors: Morten Hostrup, PhD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Condition: Asthma Interventions: Drug: TEV-56248; Drug: Albuterol sulfate Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis
Condition: Allergic Rhinitis Interventions: Drug: azelastine/fluticasone 137/50 mcg nasal spray; Drug: Dymista™ Sponsor: Synmosa Biopharma Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Condition: Asthma Interventions: Drug: TEV-56248; Drug: Albuterol sulfate Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis
Condition: Allergic Rhinitis Interventions: Drug: azelastine/fluticasone 137/50 mcg nasal spray; Drug: Dymista™ Sponsor: Synmosa Biopharma Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Condition: Asthma Interventions: Drug: TEV-56248; Drug: Albuterol sulfate Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis
Condition: Allergic Rhinitis Interventions: Drug: azelastine/fluticasone 137/50 mcg nasal spray; Drug: Dymista™ Sponsor: Synmosa Biopharma Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Condition: Asthma Interventions: Drug: TEV-56248; Drug: Albuterol sulfate Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis
Condition: Allergic Rhinitis Interventions: Drug: azelastine/fluticasone 137/50 mcg nasal spray; Drug: Dymista™ Sponsor: Synmosa Biopharma Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Conditions: Asthma Interventions: Drug: TEV-56248; Drug: Albuterol sulfate Sponsors: Teva Branded Pharmaceutical Products R&D, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
